Big Pharma

Biden is No FDR and Build Back Better Legislation Proves It

October 28, 2021 UNAC Editor Austerity, Big Pharma, Capitalism, War on the Poor

by Ajamu Baraka, published on Black Agenda Report, October 27, 2021 It has to be said that this is the only possible explanation for the assertion that 2 people can block the Democrat majority in congress from doing what they have to do to keep their majority through the next general election. [jb] The idea that Joe Biden is the[…]

Trump’s Great Barrington “Herd Immunity” Hoax

November 13, 2020 UNAC Editor Big Pharma, Capitalism, Public Health

by Jeff Mackler, published on Socialist Action, November 3, 2020 The moron Trump, perhaps the crudest specimen of capitalist cruelty these days, takes the matter one insane step further with his ongoing public and personal opposition to mandated lockdowns, mask wearing and social distancing necessitated by the uncontrolled spread of COVID-19. Trump’s current pandemic science adviser, Stanford University’s Hoover Institute[…]

Science and Stake Behind the COVID Vaccine Development

September 19, 2020 UNAC Editor Big Pharma, China, Healthcare, Public Health, US Government Action

by Lee Siu Hin, published on ImmigrantSolidarity.org, September 8, 2020 The global race to develop COVID-19 vaccine, there are the good, the bad and the ugly. On August 11th, 2020 Russia announced they had registered the world first COVID-19 vaccine, call “Sputink V”, while not yet enter the critical Phase III trail (any drugs need to pass 3-stages Phase I,[…]

US Declares a Vaccine War on the World

May 29, 2020 UNAC Editor Abuses of Empire, Big Pharma, Capitalism, Public Health, Sanctions and Economic Warfare, Trade Wars

by Prabir Purkayastha, published on Asia Times, May 27, 2020 Donald Trump launched a new vaccine war this month, but not against the virus. It was against the world. The United States and the UK were the only two holdouts in the World Health Assembly from the declaration that vaccines and medicines for Covid-19 should be available as public goods, and not under exclusive patent[…]